Literature DB >> 23766462

Successful stem cell transplant with antibody-based conditioning for XIAP deficiency with refractory hemophagocytic lymphohistiocytosis.

Austen J J Worth, Olga Nikolajeva, Robert Chiesa, Kanchan Rao, Paul Veys, Persis J Amrolia.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23766462     DOI： 10.1182/blood-2013-01-478735

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  11 in total

Review 1.  The Treatment of Inflammatory Bowel Disease in Patients with Selected Primary Immunodeficiencies.

Authors:  Dror S Shouval; Matthew Kowalik; Scott B Snapper
Journal:  J Clin Immunol       Date:  2018-06-29       Impact factor: 8.317

2.  BIRC4 Mutation: An Important Rare Cause of Uveitis.

Authors:  Matthew L Basiaga; Pamela F Weiss; Edward M Behrens
Journal:  J Clin Rheumatol       Date:  2015-12       Impact factor: 3.517

3.  Antibody Conditioning Enables MHC-Mismatched Hematopoietic Stem Cell Transplants and Organ Graft Tolerance.

Authors:  Benson M George; Kevin S Kao; Hye-Sook Kwon; Brenda J Velasco; Jessica Poyser; Angela Chen; Alan C Le; Akanksha Chhabra; Cassandra E Burnett; Devon Cajuste; Malachia Hoover; Kyle M Loh; Judith A Shizuru; Irving L Weissman
Journal:  Cell Stem Cell       Date:  2019-06-13       Impact factor: 24.633

Review 4.  X-linked inhibitor of apoptosis protein deficiency: more than an X-linked lymphoproliferative syndrome.

Authors:  Claire Aguilar; Sylvain Latour
Journal:  J Clin Immunol       Date:  2015-03-04       Impact factor: 8.317

Review 5.  How genetic testing can lead to targeted management of XIAP deficiency-related inflammatory bowel disease.

Authors:  Ole Haagen Nielsen; Eric Charles LaCasse
Journal:  Genet Med       Date:  2016-07-14       Impact factor: 8.822

6.  Novel X-Linked Inhibitor of Apoptosis Mutation in Very Early-Onset Inflammatory Bowel Disease Child Successfully Treated with HLA-Haploidentical Hemapoietic Stem Cells Transplant after Removal of αβ+ T and B Cells.

Authors:  Cristina Cifaldi; Maria Chiriaco; Gigliola Di Matteo; Silvia Di Cesare; Scarselli Alessia; Paola De Angelis; Francesca Rea; Giulia Angelino; Maria Pastore; Valentina Ferradini; Daria Pagliara; Caterina Cancrini; Paolo Rossi; Alice Bertaina; Andrea Finocchi
Journal:  Front Immunol       Date:  2017-12-22       Impact factor: 7.561

Review 7.  Inherited Immunodeficiencies With High Predisposition to Epstein-Barr Virus-Driven Lymphoproliferative Diseases.

Authors:  Sylvain Latour; Sarah Winter
Journal:  Front Immunol       Date:  2018-06-04       Impact factor: 7.561

Review 8.  Hematopoietic Stem Cell Transplantation in Primary Immunodeficiency Diseases: Current Status and Future Perspectives.

Authors:  Riccardo Castagnoli; Ottavia Maria Delmonte; Enrica Calzoni; Luigi Daniele Notarangelo
Journal:  Front Pediatr       Date:  2019-08-08       Impact factor: 3.418

9.  Hematopoietic Stem Cell Transplantation for XIAP Deficiency in Japan.

Authors:  Shintaro Ono; Tsubasa Okano; Akihiro Hoshino; Masakatsu Yanagimachi; Kazuko Hamamoto; Yozo Nakazawa; Toshihiko Imamura; Masaei Onuma; Hidetaka Niizuma; Yoji Sasahara; Hiroshi Tsujimoto; Taizo Wada; Reiko Kunisaki; Masatoshi Takagi; Kohsuke Imai; Tomohiro Morio; Hirokazu Kanegane
Journal:  J Clin Immunol       Date:  2016-11-04       Impact factor: 8.317

Review 10.  Evolution of Our Understanding of XIAP Deficiency.

Authors:  Anne C A Mudde; Claire Booth; Rebecca A Marsh
Journal:  Front Pediatr       Date:  2021-06-17       Impact factor: 3.418
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.